4 completed, 1 recruiting. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Recruiting 1 |
| Phase 2 | 2 | Completed 2 |
Follow Alcohol Use: new trials by email Literature Review of Alcohol Use trials Research Report on Alcohol Use
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion, 0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion, 25 mg Diphenhydramine (5 min) + Normal Saline - Alcohol Use Disorder (AUD), Alcohol-Related Disorders | Phase 1 | Recruiting | Yale University | 63 | 2025-08-04 | 2026-09-10 |
| St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene Low dose naltrexone, Nalmefene - HIV Infection, Alcohol Use | Phase 1 / Phase 2 | Completed | Boston Medical Center | 11 | 2018-07-03 | 2020-08-24 |
| Smartphone Technology: Young Adult Drinking Smartphone breathalyzer device/app use, BAC estimator app use, Text messaging procedure - Alcohol Use, Alcohol Drinking | Phase 1 / Phase 2 | Completed | University of Florida | 110 | 2016-11-01 | 2024-02-26 |
| Community-Based Integrated Treatment for Adolescents Integrated Cognitive Behavioral Therapy, Standard Care - Depression, Alcohol Use | Phase 1 | Completed | Brown University | 114 | 2012-07-01 | 2018-01-23 |
| Stepped Care for Mandated College Students Step 1: Minimal Intervention, Step 2: Brief Motivational Intervention, Alcohol Assessment - Alcohol Use | Phase 1 | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 598 | 2006-10-01 | 2016-09-21 |
Alcohol Drinking (5) · Alcohol-Related Disorders (1) · Alcoholism (1) · Depression (1) · Drinking Behavior (1) · HIV Infections (1) · Harm Reduction (1) · Pain (1)
Behavior (5) · Drinking Behavior (4) · Behavioral Symptoms (1) · Blood-Borne Infections (1) · Chemically-Induced Disorders (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · Mental Disorders (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · RNA Virus Infections (1)
Diphenhydramine (1) · Ethanol (1) · N,N-Dimethyltryptamine (1) · Naltrexone (1) · Saline Solution (1) · Standard of Care (1) · Therapeutics (1) · nalmefene (1)
Boston Medical Center (1) · Brown University (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · University of Florida (1) · Yale University (1)
United States (4) · Russia (1)
Anahita Bassir Nia, MD (1) · Anthony Spirito, Ph.D. (1) · Brian E. Borsari, PhD (1) · Jeffrey H. Samet, MD, MA, MPH (1) · Robert F Leeman, Ph.D. (1)
PMID 17574344, PMID 18612578, PMID 18781243, PMID 20116962, PMID 21193284, PMID 22924334, PMID 24512944, PMID 26098125, PMID 26402350, PMID 26460571, PMID 27936818, PMID 33607509, PMID 33682527, PMID 34238628, PMID 34766785
R01AA020705 (1), R21AA023368 (1), R21AA030649 (1), UH2AA026193 (1)